RECLUDIX PHARMA
Recludix pharma is a developing platform to discover potent and selective inhibitors of challenging protein targets. The platform approach integrates custom generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity.
RECLUDIX PHARMA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.recludixpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1-858-258-5445
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Sitelinks Search Box Euro
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Westlake Village BioPartners
Westlake Village BioPartners investment in Series A - Recludix Pharma
New Enterprise Associates
New Enterprise Associates investment in Series A - Recludix Pharma
Access Biotechnology
Access Biotechnology investment in Series A - Recludix Pharma
Official Site Inspections
http://www.recludixpharma.com Semrush global rank: 5.62 M Semrush visits lastest month: 1.51 K
- Host name: 195.165.196.104.bc.googleusercontent.com
- IP address: 104.196.165.195
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Recludix Pharma"
Home - Recludix Pharma
At Recludix, we are innovators and inventors. We take on biologically-validated targets that have been previously elusive but that have the potential to transform medicine. We are looking for …See details»
About Overview - Recludix Pharma
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets. Our platform approach integrates custom generated DNA …See details»
About - Recludix Pharma
© 2024 Recludix All Rights Reserved | Privacy Policy | Terms of Use MENU . About. Overview; Mission and Commitment; Leadership; Partners and InvestorsSee details»
Recludix Pharma - Crunchbase Company Profile
Recludix pharma is a developing platform to treat cancer patients. View contacts for Recludix Pharma to access new leads and connect with decision-makers. Recludix pharma is a developing platform to discover potent and selective …See details»
Recludix Pharma - Overview, News & Similar companies - ZoomInfo
Jun 10, 2024 · Recludix Pharma contact info: Phone number: (858) 258-5445 Website: www.recludixpharma.com What does Recludix Pharma do? Recludix is a leader in developing …See details»
Recludix Pharma - LinkedIn
For more information, please visit the company’s website at https://recludixpharma.com. If you are attending the ACR Convergence meeting, join us as we present compelling data with our...See details»
Recludix Pharma Enters into a Strategic Collaboration with Sanofi …
Jul 20, 2023 · Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets. The company’s management team includes …See details»
Recludix Pharma Launches with $60 Million Series A to Support ...
Nov 15, 2021 · Recludix has built a proprietary platform to discover potent and selective inhibitors of challenging protein targets. The platform comprises custom generated DNA-encoded …See details»
Mission and Commitment - Recludix Pharma
We are a team of industry veterans, scientists and drug developers committed to creating transformative medicines for patients, pursuing cutting-edge science, as well as creating a …See details»
Recludix Pharma to Participate in Two Investor Conferences
3 days ago · For more information, please visit the company’s website at https://recludixpharma.com. Recludix Contacts Matt Caldemeyer Chief Business Officer …See details»
Recludix Pharma Launches with $60 Million Series A to
Nov 15, 2021 · Recludix has built a proprietary platform to discover potent and selective inhibitors of challenging protein targets. The platform comprises custom generated DNA-encoded …See details»
Recludix Pharma | Insights
Jul 20, 2023 · Scrip asked 30 industry leaders to share their thoughts around what the biopharma industry will do – and what it needs to do – to advance diversity, equity and inclusion (DEI) this …See details»
Recludix Pharma, Sanofi Enter into Collaboration on Oral
Jul 24, 2023 · Recludix Pharma, a pharmaceutical technology company, has announced a partnership with Sanofi to commercialize oral small molecule STAT6 (signal transducer and …See details»
Recludix Pharma Enters into a Strategic Collaboration with Sanofi …
SAN DIEGO, CA, July 20, 2023 – Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, today announced that …See details»
Recludix Pharma to Participate in Two Investor Conferences in …
3 days ago · SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in discovery of inhibitors of challenging targets for inflammatory disease, today announced that …See details»
Careers - Recludix Pharma
We take on challenging biologically-validated targets that have been previously elusive but that have the potential to transform medicine. The work you do at Recludix will have a direct impact …See details»
Recludix Pharma Presents Preclinical Data from its STAT3
SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, …See details»
Recludix Pharma Presents Data Demonstrating Oral STAT3 …
May 17, 2024 · For more information, please visit the company’s website at https://recludixpharma.com. Recludix Contacts: Alexandra Santos …See details»
Recludix Pharma Enters into a Strategic Collaboration with
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, …See details»
Corporate Presentation - Recludix Pharma
Update featured image and file uploadSee details»